期刊文献+

特发性肺动脉高压CT肺动脉成像的诊断价值 被引量:9

Diagnostic value of CT pulmonary artery imaging for idiopathic pulmonary artery hypertension
原文传递
导出
摘要 目的探讨CT肺动脉成像(CTPA)在特发性肺动脉高压(IPAH)中的诊断价值。方法回顾性分析2012年1月至2015年11月浙江大学医学院附属邵逸夫医院经右心漂浮导管检查(RHC)确诊的IPAH患者加例。对肺实质、肺问质、纵隔淋巴结、心包和胸膜腔在CTPA检查中的表现进行分析,并测量心血管管径,包括右心室及左心室短轴最大径和主肺动脉、右肺动脉、左肺动脉、右下肺动脉、升主动脉及降主动脉直径,计算主肺动脉直径与升主动脉直径比值(rPA)、升主动脉与降主动脉直径比值(rAD)及右心室与左心室短轴最大径比值(RV/LV)。采用Spearman相关分析比较性别、肺、淋巴结、心包及胸膜改变与肺动脉压(PAP)之间的相关性;采用独立样本t检验对轻中度肺动脉高压组(4例)与重度肺动脉高压组(16例)间各心血管径的测量与计算值进行比较分析;采用Pearson相关分析对不同年龄组(〈50岁和≥50岁)的肺动脉压进行比较分析。结果20例患者中,片状渗出性改变7例,灌注不均“马赛克征”表现5例,“小叶中心性磨玻璃样肺结节”样渗出3例,纵隔淋巴结肿大6例,心包积液10例,其中4例合并胸腔积液,支气管动脉扩张4例,继发右肺动脉干栓塞1例。有无胸腔积液出现两组间肺动脉压力差异有统计学意义(r值为0.445,P=0.049);左室短轴最大径、左肺动脉直径、右肺动脉直径、升主动脉直径、降主动脉直径及rPA在轻中度与重度肺动脉高压间的差异有统计学意义(t值分别为3.194、-3.393、-7.771、10.299、11.394、-12.715;均P〈0.05)。不同年龄组的肺动脉压力差异有统计学意义(r值为-0.481,P=0.032)。结论CTPA检查是诊断IPAH非常重要的检查方法,两肺、纵隔、心包膜、胸膜腔的表现以及心血管管径的大小对IPAH诊断及压力的评估有重要的参考价 Objective To evaluate the diagnostic value of CT pulmonary artery (CTPA) imaging with idiopathic pulmonary artery hypertension (IPAH). Methods A total of 20 patients with right heart catheterization (RHC) proven IPAH were retrospectively analyzed between January 2012 and November 2015. The imaging was analyzed including pulmonary parenchyma, pulmonary interstitial, mediastinal lymph nodes,pericardium and pleural cavity on the CTPA examination. Cardiovascular parameters were measured in CTPA including right ventricle biggest short axis diameter (RVD), left ventricle biggest short axis diameter (LVD), main pulmonary artery diameter (MPAD), right pulmonary artery diameter (RPAD), left pulmonary artery diameter (LPAD), right low pulmonary artery diameter (RLPAD), ascending aorta diameter (AAD) and descending aorta diameter ( DAD), and parameters were calculated including the ratio of the main pulmonary and ascending aorta diameter (rPA) ,the ratio of the ascending and descending aorta diameter (rAD), the ratio of the right ventrieular and left ventricular short axis diameter (RV/LV). The relationship between sex, pulmonary, lymph nodes, pericardium, pleural and pulmonary arrery pressure (PAP) was analyzed by Spearman rank correlation analysis. All the parameters between mild-moderate (4 cases) and severe (16 cases) PAH were analyzed by independent sample t test. PAP of different age ( 〈 50 years and ≥ 50 years) groups was analyzed by Pearson correlation analysis. Results Of 20 cases,7 cases showed patch exudative change, 5 cases showed "mosaic pattern" inhomogeneous perfusion, 3 cases displayed ill-defined centrilobular nodules, 6 cases manifested mediastinal lymphadenopathy, 10 cases had pericardial effusion including 4 cases of pleural effusion, 4 cases of dilated bronchial artery, 1 cases of secondary right pulmonary artery embolism. When comparing the presence or absence of pleural effusion, these was statistical difference of PAP (
出处 《中华医学杂志》 CAS CSCD 北大核心 2016年第3期172-176,共5页 National Medical Journal of China
关键词 体层摄影术 X线计算机 高血压 肺性 诊断技术 心血管 Tomography, X-ray computed Hypertension, pulmonary Diagnostic techniques, cardiovascular
  • 相关文献

参考文献16

  • 1董林,何建国,单广良,卢献灵,曾伟杰,柳志红,周达新,曹华,倪新海,王广义,沈节艳,田红艳,孙云娟,顾晴,赵智慧,程显声,熊长明.特发性肺动脉高压150例临床分析[J].中华心血管病杂志,2012,40(8):657-661. 被引量:6
  • 2Tang K J, Robbins IM, Light RW. Incidence of pleural effusions in idiopathic and familial pulmonary arterial hypertension patients [J]. Chest, 2009, 136 ( 3 ) : 688-693. DOI: 10. 1378/chest. 08- 0659. 被引量:1
  • 3Bergin CJ, Park KJ. Lymph node enlargement in pulmonary arterial hypertension due to chronic thromboembolism [ J ]. J Med Imaging Radiat Onco1,2008,52 ( 1 ) : 18-23. DOI : 10.1111/j. 1440-1673. 2007. 01905. x. 被引量:1
  • 4Willemink MJ, van Es HW, Koobs L, et al. CT evaluation of chronic thromboembolic pulmonary hypertension [ J ]. Clin Radiol, 2012,67(3 ) :277-285. DOI:10. 1016/j. crad. 2011.09. 012. 被引量:1
  • 5Wiliflska E, Oniszh K, Augustynowicz-Kope6 E, et al. Non- tuberculous myeobacterial lung disease ( NT MLD ) in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension [ J ]. Pneumonol Alergol Po1,2014,82 (6) :495-502. DOI : 10. 5603/PiAP. 2014. 0066. 被引量:1
  • 6Ameli-Renani S, Rahman F, Nair A, et al. Dual-energy CT for imaging of pulmonary hypertension: challenges and opportunities [ J]. Radiographics ,2014,34 ( 7 ) : 1769-1790. DOI : 10.1148/rg. 347130085. 被引量:1
  • 7Rossi A, Attina D, Borgonovi A, et al. Evaluation of mosaic pattern areas in HRCT with Min-IP reconstructions in patients with pulmonary hypertension: could this evaluation replace lung perfusion seintigraphy? [ J]. Eur J Radiol,2012,81 (1) : el-e6. DOI : 10. 1016/j. ejrad. 2010.09. 032. 被引量:1
  • 8Kaeprzak A, Szturmowiez M, Burakowska B, et al. Abnormalities in high-resolution computed tomography of the lungs in patients with idiopathic pulmonary arterial hypertension-correlation with hemodynamic parameters and prognostic significance [ ~ 1. Pneumonol Alergol Po1,2009,77 ( 1 ) :23-30. 被引量:1
  • 9Moua T, Levin DL, Carmona EM,et al. Frequency of mediastinal lymphadenopathy in patients with idiopathic pulmonary arterial hypertension [ J ]. Chest, 2013,143 ( 2 ) : 344-348. DOI : 10. 1378/ chest. 12-0663. 被引量:1
  • 10Pastis NJ Jr, Van Bakel AB, Brand TM, et al. Mediastinal lymphadenopathy in patients undergoing cardiac transplant evaluation[ J]. Chest,2011,139 (6) : 1451-1457. DOI: 10. 1378/ chest. 10-1386. 被引量:1

二级参考文献21

  • 1Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation, 2010, 122 : 156-163. 被引量:1
  • 2Falcetti E, Hall SM, Phillips PG, et al. Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med, 2010,182 : 1161-1170. 被引量:1
  • 3Sandoval J, Bauerle O, Gomez A, et al. Primary pulmonary hypertension in children: clinical characterization and survival. J Am Coll Cardiol, 1995,25:466-474. 被引量:1
  • 4Wensel R, Opitz CF, Anker SD, et al. Assessment of survival in patients with primary pulmonary hypertension importance of cardiopulmonaty exercise testing. Circulation, 2002, 106: 319- 324. 被引量:1
  • 5McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology foundation task force on expert consensus documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc. ; and the Pulmonary Hypertension Association. J Am Coil Cardiol, 2009, 53 : 1573-1619. 被引量:1
  • 6Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardilogy. Eur Heart J, 2004, 25:2243- 2278. 被引量:1
  • 7ATS committee on proficiency standards for clinical pulmonary function laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med, 2002, 166:111-117. 被引量:1
  • 8D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med, 1991,115 : 343-349. 被引量:1
  • 9Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med, 1987,107 : 216-223. 被引量:1
  • 10Peacock AJ, MuFphy NF, McMurray JJ, et al. An epidemiological study of pulmonary arterial hypertension. Eur Respir J,2007,30: 104-109. 被引量:1

共引文献5

同被引文献78

引证文献9

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部